Management of acute myocardial infarction 1990: a perspective.
Rising costs have reached a point at which physicians must assume a major role in dealing with the cost of medicine. Little information is available regarding actual practice at the community hospital level. In order to develop some insight on this issue, a survey of cardiovascular specialists was conducted regarding management of acute myocardial infarction in 1990. The results indicate a major lack of correlation between efficacy, cost, and practice patterns in terms of current knowledge. Perhaps legal concerns have contributed to these current practice patterns. Clearly, aside from choice of thrombolytic agent and/or PTCA, early treatment of acute myocardial infarction has emerged as a most important factor in reducing mortality.
Vogel
J H
JH
Santa Barbara Heart and Lung Institute, Goleta Valley Community Hospital, California.
D015906:Angioplasty, Balloon, Coronary / Q000191:economics / Q000706:statistics & numerical data; D002170:Canada; D006328:Cardiac Catheterization / Q000706:statistics & numerical data; D002309:Cardiology / Q000706:statistics & numerical data; D006801:Humans; D009203:Myocardial Infarction / Q000191:economics / Q000628:therapy*; D010818:Practice Patterns, Physicians' / Q000191:economics*; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000191:economics* / Q000706:statistics & numerical data; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014481:United States
D013300:Streptokinase; D010959:Tissue Plasminogen Activator